U.S. market Open. Closes in 2 hours 6 minutes

BCTX | BriaCell Therapeutics Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-07-312023-07-312022-07-312021-07-312020-07-312019-07-312018-07-312017-07-312016-07-312015-07-312014-07-312013-07-312012-07-312011-07-312010-07-312009-07-312008-07-312007-07-312006-07-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue82.58K15.53K15.14K15.57K13.99K14.27KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-82.58K-15.53K-15.14K-15.57K-13.99K-14.27KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses32.73M23.27M-3.39K-3.69M-1.38M-946.42K-1.07M2.58M1.67M1.44M437.27K424.26K551.84K1.05M324.57K233.87K114.12K129.06K8.58K
Selling, General & Admin5.97M7.94M7.27M-3.67M-1.37M-932.17K-1.05M876.16K942.02K1.33M436.17K423.86K556.06K1.05M323.27K203.86K114.12K129.06K8.58K
Research & Development26.75M15.34M8.02M1.32M2.22M3.74M2.39M1.71M723.43K105.82KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/A-15.29M-1.33M-2.24M-3.75M-312.92K290.001.79K565.001.21K404.00-4.23K2.40K1.33K2.33KN/AN/AN/A
Operating Income-32.81M-23.27M-15.29M3.69M1.38M946.42K-3.82M-2.58M-1.67M-1.44M-437.27K-424.26K-1.20M-1.05M-324.57K-233.87K-114.12K-129.06K-8.58K
Other Expenses / Income28.02M2.97M3.74M-6.84M-85.10KN/A-1.59M634.11K481.60K-1.24M-7.71M55.56K202.71K-37.16K-595.34K2.51KN/AN/AN/A
Before Tax Income-4.79M-20.30M-11.55M3.69M1.38M946.42K1.07M-2.58M-1.70M-2.68M-8.15M-368.69K-995.72K-1.09M-919.91K-231.36KN/AN/AN/A
Income Tax Expenses62.85K-152.62K30.73K6.58M-72.25K343.74K1.59M638.59K547.97K2.05M8.45M-44.35K-200.92K-24.03K601.48K12.46K-12.72K-5.10K1.13K
Net Income-4.79M-20.30M-11.58M-2.89M1.38M602.68K1.07M-2.58M-1.70M-2.68M-8.15M-368.69K-995.72K-1.08M-900.74K-228.81K-98.93K-116.41K-8.58K
Interest ExpensesN/AN/A979.0046.09K27.00K23.82K15.63KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding16.45M15.62M15.49M4.52M713.89K579.66K427.81K339.71K288.44K249.18K59.00K59.00K58.83K32.67K18.17K8.93K4.84K4.17K2.05K
Diluted Shares Outstanding16.45M15.62M15.49M4.52M713.89K579.66K427.81K352.98K288.44K249.18K59.00K59.00K58.83K32.67K18.17K8.93K4.84K4.17K2.05K
EBITDA-4.77M-30.67M-15.13M-8.69M-3.97M-6.67M-4.96M-3.22M-2.18M-1.80M-2.61K-462.53K-68.23K-1.01M255.79K-233.72K-114.12K-129.06K-8.58K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-4.73M-20.46M-11.55M3.74M1.34M970.24K2.67M-1.95M-1.15M-633.46K303.38K-413.05K-1.20M-1.10M-299.26K-216.36K-111.65K-121.50K-7.45K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-07-312023-07-312022-07-312021-07-312020-07-312019-07-312018-07-312017-07-312016-07-312015-07-312014-07-312013-07-312012-07-312011-07-312010-07-312009-07-312008-07-312007-07-312006-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙